Michael Gelband ExodusPoint Capital Management
Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$435M |
| 2 |
Amazon
AMZN
|
+$334M |
| 3 |
Moderna
MRNA
|
+$53.9M |
| 4 |
Linde
LIN
|
+$44.2M |
| 5 |
DTE Energy
DTE
|
+$43.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 1000 Value ETF
IWD
|
+$63.6M |
| 2 |
Comcast
CMCSA
|
+$39.7M |
| 3 |
Evergy
EVRG
|
+$38.5M |
| 4 |
Public Service Enterprise Group
PEG
|
+$38.4M |
| 5 |
Bio-Techne
TECH
|
+$30.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.37% |
| 2 | Consumer Discretionary | 10.36% |
| 3 | Financials | 7.14% |
| 4 | Industrials | 6.8% |
| 5 | Healthcare | 6.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BRMK
476
DELISTED
Broadmark Realty Capital Inc. Common Stock
BRMK
| $3.51M | 0.04% |
331,388
+89,904
| +37% | +$954K |
|
477
Ollie's Bargain Outlet
OLLI
$4.6B
| $3.51M | 0.04% |
41,697
+23,177
| +125% | +$2.02M |
|
478
Vroom Inc
VRM
$53.8M
| $3.5M | 0.04% |
1,046
+415
| +66% | +$1.41M |
|
479
Cardinal Health
CAH
$53.4B
| $3.47M | 0.04% |
+60,815
| New | +$3.55M |
|
480
International Flavors & Fragrances
IFF
$21.5B
| $3.47M | 0.04% |
+23,241
| New | +$3.34M |
|
|
WORK
481
DELISTED
Slack Technologies, Inc.
WORK
| $3.45M | 0.04% |
+77,967
| New | +$3.34M |
|
482
MDU Resources
MDU
$4.2B
| $3.44M | 0.04% |
288,496
+68,953
| +31% | +$864K |
|
483
Freshpet
FRPT
$3.55B
| $3.43M | 0.04% |
+21,068
| New | +$3.59M |
|
484
Suncor Energy
SU
$80B
| $3.41M | 0.04% |
142,283
+40,771
| +40% | +$935K |
|
485
Marathon Digital Holdings
MARA
$4.35B
| $3.34M | 0.04% |
+106,355
| New | +$3.37M |
|
486
PENN Entertainment
PENN
$2.5B
| $3.33M | 0.04% |
43,480
-35,331
| -45% | -$3.04M |
|
487
Coty
COTY
$2.41B
| $3.31M | 0.04% |
+353,918
| New | +$3.21M |
|
488
State Street SPDR S&P 500 ETF Trust
SPY
$822B
| $3.3M | 0.04% |
+7,704
| New | +$3.22M |
|
489
Church & Dwight Co
CHD
$23.4B
| $3.29M | 0.04% |
+38,561
| New | +$3.34M |
|
490
iShares MSCI Taiwan ETF
EWT
$11.3B
| $3.26M | 0.04% |
+51,000
| New | +$3.17M |
|
491
Herc Holdings
HRI
$5.41B
| $3.25M | 0.04% |
29,028
-20,025
| -41% | -$2.12M |
|
|
492
Public Service Enterprise Group
PEG
$36.2B
| $3.23M | 0.04% |
54,007
-621,613
| -92% | -$38.4M |
|
493
Elevance Health
ELV
$86.9B
| $3.21M | 0.04% |
8,408
-8,769
| -51% | -$3.35M |
|
494
Aflac
AFL
$58.2B
| $3.21M | 0.04% |
59,787
+37,890
| +173% | +$2.07M |
|
495
Comstock Resources
CRK
$4.18B
| $3.21M | 0.04% |
+480,601
| New | +$2.77M |
|
|
HTLF
496
DELISTED
Heartland Financial USA, Inc.
HTLF
| $3.2M | 0.04% |
68,160
+49,665
| +269% | +$2.47M |
|
|
SAFM
497
DELISTED
Sanderson Farms Inc
SAFM
| $3.2M | 0.04% |
17,031
+7,016
| +70% | +$1.18M |
|
498
CALL
Builders FirstSource
BLDR
$7.55B
| $3.2M | 0.04% |
+75,000
| New | +$3.48M |
|
499
Avery Dennison
AVY
$13.9B
| $3.19M | 0.04% |
+15,195
| New | +$3.19M |
|
500
Rambus
RMBS
$9.9B
| $3.17M | 0.04% |
133,773
+116,667
| +682% | +$2.35M |
|
Similar funds
Michael Gelband's Q2 2021 Portfolio in Review
As of Q2 2021, Michael Gelband held 3,092 positions worth $9.04B, up 32% from $6.86B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Michael Gelband deployed $1.88B of net new capital in Q2 2021, opening 1,032 new positions and adding to 581 existing holdings. Its largest new stake was Linde: 151,692 shares worth $43.9M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 13% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was iShares Russell 1000 Value ETF, an estimated $63.6M trimmed.
- Michael Gelband's largest Q2 2021 buy was Linde: 151,692 shares worth $43.9M.
- Michael Gelband added most to Microsoft in Q2 2021, an estimated $435M increase.
- Michael Gelband's biggest Q2 2021 reduction was iShares Russell 1000 Value ETF, cutting an estimated $63.6M.
- Michael Gelband fully exited Charles River Laboratories in Q2 2021, selling an estimated $27.9M.
- Michael Gelband's ten largest holdings make up 35% of its $9.04B portfolio in Q2 2021.
- Michael Gelband opened 1,032 new positions and closed 820 in Q2 2021.
- Michael Gelband's portfolio value rose 32% quarter-over-quarter to $9.04B.
Based on ExodusPoint Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.